BRD4 and cancer: For example, inhibition of BRD4, the most studied and targeted BET protein, enhances antigen presentation via increasing MHC class I expression,473 converts TAMs towards the M1-like phenotype,474 and reduces the expression of immune checkpoints (PD-L1 expression on DCs, TAMs and cancer cells474,475 and CD47 expression on cancer cells476).